Work

Phase I Study of Triapine® and Cytarabine (ara-C) in Patients with Relapsed or Refractory Acute Leukemias and High-Risk Myelodysplastic Syndrome (MDS).

Year: 2005

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v106.11.4925.4925

Authors: Karen W.L. Yee, Jorge Cortes, Guillermo Garcia-Manero, Srdan Verstovsek, Alessandra Ferrajoli, William G. Wierda, Deborah Thomas, Stefan Faderl, Ivan King, Susan M. O’Brien, Mario Sznol, Francis J. Giles

Institutions: The University of Texas MD Anderson Cancer Center, Vion Pharmaceuticals (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2564894377

FWCI:

Cites:

Cited by:

Related to: 10